Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The department plans to fund Canada's Drug Agency to conduct health technology assessments and align regulatory approvals with reimbursement recommendations [Source: hrreporter.com/focus-areas/compensation-and-benefits/canada-first-in-g7-to-approve-generic-ozempic/394374]
Other key highlights of the product include: The product was intentionally designed both in size and packaging
government is considering formalizing the program beginning in 2028 after the pilot concludes
It is slower-acting and longer-lasting than regular insulin, designed to provide coverage over a larger portion of the day
Key Leaders: Jeffrey Finer, MD, CEO & Co-founder
US$ 22.03
US$ 24.26
US$ 20.64
US$ 21.37
